Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study.
Fujimoto A, Koutake Y, Hisamatsu D, Ookubo N, Yabuuchi Y, Kamimura G, Kai T, Kozono A, Ootsu T, Suzuki H, Matsuo K, Kuwahara K, Oiwane Y, Nagata Y, Tanimoto K, Sato E, Suenaga M, Uehara T, Ikari A, Endo S, Hiraki Y, Kawamata Y.
Fujimoto A, et al. Among authors: uehara t.
Cancer Immunol Immunother. 2024 Dec 30;74(1):33. doi: 10.1007/s00262-024-03874-4.
Cancer Immunol Immunother. 2024.
PMID: 39739038
Free PMC article.
No abstract available.